Teladoc (TDOC) Misses Q2 EPS

Go back to Teladoc (TDOC) Misses Q2 EPS

Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'

July 28, 2022 12:26 PM EDT

JPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.

The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More